At a glance
ClinicalIndex Comparison RecordN/ACompleted· 498 enrolled
Drug / intervention
no interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Establishment for Thromboelastography Normal Reference Values of Healthy Adults in China Hunan Province: A Multicenter Observational Study
The Third Xiangya Hospital of Central South University·observational·Posted May 10, 2017·Updated Mar 27, 2018
In Brief
An observational study evaluating no intervention for Coagulopathy and Blood Transfusion Complication. Completed, enrolled 498 participants across 1 site.
Detailed Summary
The purpose of this study was to establish the normal reference range of Thrombelastogram parameters in Hunan by a multicenter study, and to analyze the specificity of Thrombelastogram detection and the influence of gender, age and blood type on Thrombelastogram. The study will provide basic data and statistical basis for the establishment of normal reference range of Thrombelastogram in Hunan.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoagulopathy, Blood Transfusion Complication
CountriesChina
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartJun 2017
Primary CompletionJan 2018
Study CompletionMar 2018
TodayJul 2026
First PostedMay 10, 2017
Enrollment StartJun 5, 2017
Primary CompletionJan 1, 2018
Study CompletionMar 10, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 9.1 years ago
Interventions
no interventionother
no intervention